Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    p07037
Show Display Options
Rank Status Study
1 Completed Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease;   Idiopathic Parkinson's Disease
Interventions: Drug: preladenant;   Drug: Placebo to preladenant
2 Terminated An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease
Interventions: Drug: Preladenant;   Drug: Rasagiline;   Drug: Placebo to preladenant;   Drug: Placebo to rasagiline

Indicates status has not been verified in more than two years